ProMIS Neurosciences Antibodies Inhibit Accumulation of Alzheimer’s-linked Protein, Study Shows
Antibodies that ProMIS Neurosciences created to target molecules associated with Alzheimer’s inhibit the accumulation of the amyloid beta protein that is a hallmark of the disease. The company’s researchers used two computer algorithms, ProMI and Collective Coordinates, to predict amyloid beta misfolding and five disease-specific targets for antibodies, according to a presentation…